Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
about
Vedolizumab for the treatment of ulcerative colitis and Crohn's diseaseUstekinumab for the treatment of Crohn's disease: can it find its niche?A Systematic Review of the Cost-Effectiveness of Biologics for the Treatment of Inflammatory Bowel DiseasesNanomedicine and drug delivery strategies for treatment of inflammatory bowel diseaseAdvances in refractory ulcerative colitis treatment: A new therapeutic target, Annexin A2Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel diseaseReview article: anti-adhesion therapies for inflammatory bowel diseaseInflammatory pathways of importance for management of inflammatory bowel diseaseTreating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseasesRedeeming an old foe: protective as well as pathophysiological roles for tumor necrosis factor in inflammatory bowel diseaseAn indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitisSystematic review: treatment pattern and clinical effectiveness and safety of pharmaceutical therapies for Crohn's disease in EuropeCytokines, IBD, and colitis-associated cancerIBS-like symptoms in patients with ulcerative colitisRisk of Biologic Therapy-Associated Progressive Multifocal Leukoencephalopathy: Use of the JC Virus Antibody Assay in the Treatment of Moderate-to-Severe Crohn's DiseaseStrategies for the prevention of postoperative recurrence of Crohn's disease.Biological treatment of Crohn's disease.Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery?Retrospective cohort study of anti-tumor necrosis factor agent use in a veteran populationEvaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents.Predicting Pre-emptive Discussions of Biologic Treatment: Results from an Openness and Preference Survey of Inflammatory Bowel Disease Patients and Their Prescribers.Postprandial response of bone turnover markers in patients with Crohn's disease.Medical management of Crohn's disease.Clinical use of anti-TNF therapy and increased risk of infectionsA medicoeconomic review of early intervention with biologic agents in the treatment of inflammatory bowel diseases.Serial intralesional injections of infliximab in small bowel Crohn's strictures are feasible and might lower inflammation.Vitamin D deficiency in patients with intestinal malabsorption syndromes--think in and outside the gut.Comparative efficacy of pharmacologic interventions in preventing relapse of Crohn's disease after surgery: a systematic review and network meta-analysisTumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysisStimulation of duodenal biopsies and whole blood from dogs with food-responsive chronic enteropathy and healthy dogs with Toll-like receptor ligands and probiotic Enterococcus faecium.The th17/treg immune balance in ulcerative colitis patients with two different chinese syndromes: dampness-heat in large intestine and spleen and kidney yang deficiency syndromeInfliximab to treat Crohn's disease: an update.Managing refractory Crohn's disease: challenges and solutionsPRISMA--efficacy and safety of vedolizumab for inflammatory bowel diseases: a systematic review and meta-analysis of randomized controlled trials.Management of perianal fistulas in Crohn's disease: an up-to-date reviewFrom historical perspectives to modern therapy: a review of current and future biological treatments for Crohn's diseaseCrotoxin from Crotalus durissus terrificus is able to down-modulate the acute intestinal inflammation in mice.Adverse symptoms with anti-TNF-alpha therapy in inflammatory bowel disease: systematic review and duration-response meta-analysis.Select a suitable treatment strategy for Crohn's disease: step-up or top-down.Systematic review with meta-analysis: faecal diversion for management of perianal Crohn's disease.
P2860
Q24630083-EE270AE5-8211-4725-9847-E85C354D2123Q26771890-CD568930-C3E1-4873-A3F6-5ACDB40D5225Q26775384-33BF85FC-61D7-4D6B-8DB4-FF3297D17ADFQ26777400-A742BCE0-1F8F-4495-BB3E-68BE4C6C1CDEQ26798299-50FC48AD-B7D8-4CF6-A5EE-21354A3026D9Q26866940-26E5979A-CAAA-479F-A576-D6D1022CFA75Q26999705-A4BA7981-85D1-49F0-B9E8-10E49CDB6984Q27005445-C08412B7-3748-4915-813F-6B1D80CA9ADEQ27008246-7CC453D2-D821-4035-A057-7E3C114BE69DQ27027630-BDC22A10-B7D2-4873-BB29-26AE916E9AFDQ28079322-33120EDB-37A3-4A82-B59E-C39B30D6DBBBQ28080300-99DD9155-D101-4023-BCBE-553C7FC5EF6EQ28080901-12CEA180-D2D8-4480-8A06-939D8D2BE609Q28088663-97EFD74C-EB21-4E0E-B5DD-97B47BC432D1Q28538974-2E448B47-F72B-4324-AE5B-D85DAB56F0F8Q31122078-5EA47E29-47E7-4BBE-A7A1-FD6972AE57BCQ33354991-B6D23BB7-3820-421F-AFEF-2B07903C3064Q33564081-90B8E579-C354-4EE7-88EF-451AA866C646Q33667897-3BEBA1F7-229D-400B-BC0A-6E36AC2BF741Q33726030-C62FD67A-A151-4B1F-93B5-F89EAEBF0E20Q33844419-89D1D15C-DA8C-4D0B-AA4E-5AA7EC0D52FCQ33948406-0DC7382B-46D7-4A78-9491-23D7F1C1C892Q34046139-3DF86212-920A-4E13-BFCA-B3BC8164B3FAQ34338096-2973FA80-A1C8-4764-99B6-9AC3171CAF67Q34353032-576142A6-6185-4DF4-9BC0-7F3075BC6A56Q34418894-5A11EBE5-7DFF-4A7B-BF45-BE0A2B1D1BBAQ34491388-F9F38ACF-2A69-4BD5-A4E3-E1A954734990Q34758714-4B2ED157-0B44-4C14-94A3-8F498BC004EFQ35052356-2BF69032-4A4F-46DA-B778-A17F9522F542Q35165968-65B72A11-42E1-4251-BDC2-9902E1D7B875Q35177977-FBE004CB-60D5-45FC-9409-442ED842D6E1Q35304737-CE222915-EE3B-42F5-9577-15536A3A52B1Q35460367-2106B248-1720-4F4A-8693-25F9321852B3Q35530872-A32B2B89-E910-4CC5-B3D4-B162DD2B648DQ35558085-8404047E-D17D-4B14-BD38-529903C6DC5DQ35559305-81E6FAC0-8982-47DB-9716-58EC8D26456AQ35597581-14B27A9F-F4DF-4387-B623-76B9E33080B8Q35645531-29BF1903-22C2-4447-B823-7F23D62859AFQ35721537-1BD03891-D8FE-4967-ACDA-1C72D88FCFCCQ35743069-54915D4E-91D7-4392-BE49-8A5815032328
P2860
Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy of biological therapi ...... atic review and meta-analysis.
@en
Efficacy of biological therapi ...... atic review and meta-analysis.
@en-gb
Efficacy of biological therapi ...... atic review and meta-analysis.
@nl
type
label
Efficacy of biological therapi ...... atic review and meta-analysis.
@en
Efficacy of biological therapi ...... atic review and meta-analysis.
@en-gb
Efficacy of biological therapi ...... atic review and meta-analysis.
@nl
prefLabel
Efficacy of biological therapi ...... atic review and meta-analysis.
@en
Efficacy of biological therapi ...... atic review and meta-analysis.
@en-gb
Efficacy of biological therapi ...... atic review and meta-analysis.
@nl
P2093
P2860
P50
P921
P356
P1476
Efficacy of biological therapi ...... atic review and meta-analysis.
@en
P2093
Khurram J Khan
Nicholas J Talley
Stephen B Hanauer
P2860
P304
644-59, quiz 660
P356
10.1038/AJG.2011.73
P407
P577
2011-03-15T00:00:00Z